9 suspended. 9 Phase 2, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Suspended 9 |
| Phase 3 | 3 | Suspended 3 |
Follow Mr Imaging: new trials by email Literature Review of Mr Imaging trials Research Report on Mr Imaging
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma Biopsy Procedure, Biospecimen Collection, Lomustine - Progressive Glioblastoma, Recurrent Glioblastoma | Phase 2 | Suspended | National Cancer Institute (NCI) | 184 | 2024-11-08 | 2026-11-03 |
| Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Multiple Myeloma | Phase 2 | Suspended | National Cancer Institute (NCI) | 84 | 2024-08-27 | 2026-10-19 |
| Testing the Combination of the Anticancer Drug Durvalumab With Chemotherapy (Gemcitabine and Cisplatin) at Improving Outcomes for High-Risk Resectable Liver Cancer Before Surgery Biopsy Procedure, Biospecimen Collection, Cisplatin - Resectable Intrahepatic Cholangiocarcinoma | Phase 2 | Suspended | National Cancer Institute (NCI) | 27 | 2024-07-10 | 2026-09-04 |
| Testing Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug Cabozantinib in Recurrent, Metastatic, or Incurable Nasopharyngeal Cancer Biospecimen Collection, Cabozantinib S-malate, Computed Tomography - Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma | Phase 2 | Suspended | National Cancer Institute (NCI) | 50 | 2024-02-19 | 2026-11-02 |
| Cemiplimab Plus Fianlimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surgery Cemiplimab, Computed Tomography, Biospecimen Collection - Locally Advanced Basal Cell Carcinoma, Basal Cell Carcinoma | Phase 2 | Suspended | Thomas Jefferson University | 70 | 2023-07-05 | 2026-06-10 |
| A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma Bone Scan, Cabozantinib S-malate, Cisplatin - High Grade Osteosarcoma, Localized Osteosarcoma | Phase 2 / Phase 3 | Suspended | National Cancer Institute (NCI) | 1122 | 2023-03-03 | 2026-10-27 |
| Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial Atezolizumab, Biospecimen Collection, Computed Tomography - Extensive Stage Lung Small Cell Carcinoma | Phase 2 / Phase 3 | Suspended | National Cancer Institute (NCI) | 138 | 2021-01-07 | 2026-10-29 |
| Stereotactic Body Radiation Therapy in Treating Patients With Oligometastatic Renal Cell Carcinoma Biopsy, Biospecimen Collection, Computed Tomography - Metastatic Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8 | Phase 2 | Suspended | M.D. Anderson Cancer Center | 123 | 2018-06-14 | 2026-10-06 |
| Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer Atezolizumab, Biopsy Procedure, Biospecimen Collection - Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 | Phase 2 / Phase 3 | Suspended | National Cancer Institute (NCI) | 613 | 2013-03-22 | 2026-11-02 |
Carcinoma, Basal Cell (1) · Carcinoma, Renal Cell (1) · Glioblastoma (1) · Multiple Myeloma (1) · Nasopharyngeal Carcinoma (1) · Osteosarcoma (1) · Squamous Cell Carcinoma of Head and Neck (1)
National Cancer Institute (NCI) (7) · M.D. Anderson Cancer Center (1) · Thomas Jefferson University (1)
United States (9) · Canada (2) · Australia (1) · Hong Kong (1) · New Zealand (1)
Ari J Rosenberg (1) · Chad Tang (1) · Hop S Tran Cao (1) · Joseph Curry, MD (1) · Michael Lim (1) · Michael W Bishop (1) · Paul M Harari (1) · Quynh-Nhu Nguyen (1) · Sascha A Tuchman (1)
PMID 34717797, PMID 40915303, PMID 41671459
U10CA180821 (3), U10CA180868 (2), P30CA016672 (1), U10CA021661 (1), U10CA180886 (1), UM1CA186688 (1)